Skip to main content

Published locations for Triple threat: Novel agent shows potent T2D weight loss in phase 1

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Triple threat: Novel agent shows potent T2D weight loss in phase 1

User login

  • Reset your password
  • /content/triple-threat-novel-agent-shows-potent-t2d-weight-loss-phase-1
  • /clinicalendocrinologynews/article/258149/diabetes/triple-threat-novel-agent-shows-potent-t2d-weight
  • /ecardiologynews/article/258149/diabetes/triple-threat-novel-agent-shows-potent-t2d-weight-loss-phase
  • /cardiology/article/258149/diabetes/triple-threat-novel-agent-shows-potent-t2d-weight-loss-phase-1
  • /endocrinology/article/258149/diabetes/triple-threat-novel-agent-shows-potent-t2d-weight-loss-phase-1
  • /type-2-diabetes-icymi/article/258149/diabetes/triple-threat-novel-agent-shows-potent-t2d-weight-loss
  • /breast-cancer-icymi/article/258149/diabetes/triple-threat-novel-agent-shows-potent-t2d-weight-loss
  • /b-cell-lymphoma-icymi/article/258149/diabetes/triple-threat-novel-agent-shows-potent-t2d-weight-loss